Publications

Skip to content

Publications

Explore Flatiron-authored research

Analysis of real-world progression and insufficient response variables and related endpoints among patients with non-Hodgkin lymphoma

Advances in Therapy

Richey M, Fullerton C, Zhang Q, et al

March 2025

publication-summary-analysis-of-real-world-progression-with-insufficient-response-variables-and-related-endpoints-among-patients-with-non-hodgkin-lymphoma

1,800 publications—and counting

To date, over 1,800 publications—authored by either Flatiron or our partners—have used Flatiron’s real-world data

Explore a list of all publications

See the impact of our data

Database Characterization Guide

An overview of Flatiron Health EHR-derived US data for journal reviewers and readers to better understand the data used in publications

Review our guide

Explore our summaries of Flatiron-authored research

Disease area

Acute myeloid leukemia

Breast cancer

Chronic lymphocytic leukemia

Colorectal cancer

Diffuse large B-Cell lymphoma

Gastric/Esophageal cancer

Head and neck cancer

Hepatocellular carcinoma

Melanoma

Metastatic breast cancer

Multiple myeloma

Non-small cell lung cancer

Ovarian cancer

Pancreatic cancer

Prostate cancer

Renal cell carcinoma

Small cell lung cancer

Tumor agnostic

Urothelial cell carcinoma

Topics

Comparative effectiveness

Drug discovery

HTA and market access

Health equity

Label expansion

Machine learning

Methodology

Prospective study

Quality improvement

Quality reporting

Regulatory

Resistance ID

Treatment patterns

Unmet need

Showing 9 of 0 results

ISPOR Europe
October 2025
Incidence of neutropenia adverse events identified in electronic health care records among initiators of CDK4/6 inhibitors with advanced breast cancer in the UK
Taylor L, Horne E, Samani A, et al.
ISPOR Europe
October 2025
Assessing bias in LLM-extracted real-world data: A health equity analysis of access to care and outcomes in metastatic breast cancer
Mbah O, Ho G, Keane C, Yuan Q, Ryals C.
ISPOR Europe
October 2025
Real-world insights into prostate cancer management using EHR-derived data from the UK
Horne E, Samani A, Sujenthiran A, et al.
ISPOR Europe
October 2025
Transportability of overall survival in multiple myeloma from the US to Germany: A benchmarking study
Horne E, DiBonaventura M, Thuresson P, et al.
ISPOR Europe
October 2025
Real-world study of breast cancer epidemiology and treatment patterns: A pilot study to assess EHR-derived data in the United Kingdom
McMahon P, Nolan K, Sadetsky N, Hodgeson M, Adamson B, Samani A.
ISPOR Europe
October 2025
Fit-for-purpose real-world data: Lessons from FDA QCARD and EMA Data Quality Framework
Chen A, Taylor L, Palladino M L, Maniuszko V.
ISPOR Europe
October 2025
Descriptive comparison of patient characteristics and treatment patterns in metastatic NSCLC: US and France cohorts to inform transportability
Antoine A, Robain M, Mpofu P, et al.
ISPOR Europe
October 2025
Laboratory testing patterns in patients with breast cancer treated With CDK4/6 Inhibitors: A multi-country electronic health record study from the UK, Germany, and Japan
Horne E, Samani A, Zhang Q, et al.
ISPOR Europe
October 2025
Advancing real-world evidence in diffuse large B-Cell lymphoma: Insights from EHR-derived data in the UK
Horne E, Buhl C, Downing T, Pittel H, Adamson B

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Clinical Research
Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Cookie Settings
© FLATIRON HEALTH® 2025